Stephen Smith

23PUBLICATIONS

134CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursImmunology not elsewhere classifiedApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (23)

Sort by Publication Date:

|Jun 17, 2026

Outcomes From the Multicenter ACCRU-LY-1804/CARiBOU TRIAL (Cytarabine, Acalabrutinib and Rituximab Integrated With Bortezomib-Based Outpatient Therapy) in 1st Line Mantle Cell Lymphoma.

|Mar 19, 2026

Real-world evidence for pembrolizumab gemcitabine vinorelbine and liposomal doxorubicin in classical Hodgkin lymphoma.

Grace Baek, Gaurav Varma, Samuel Yamshon

|Jul 15, 2025

Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab.

Taylor R Brooks, Emily C Zabor, Yohanna B Bedelu

|Jun 17, 2025

Pralatrexate is effective in cytotoxic cutaneous T-cell lymphomas.

Christina Poh, Jenna M Voutsinas, Mazyar Shadman

|Feb 12, 2025

Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma.

Laura Samples, Hossein Sadrzadeh, Matthew J Frigault

|Nov 18, 2024

Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience.

Ivan J Huang, Grace T Baek, Jonathan Cohen

Pageof 4

Frequent Collaborators

Mazyar Shadman

Ajay K Gopal

Chaitra Ujjani

Ryan C Lynch

Narendranath Epperla

Edus H Warren

Adam Zayac

Adam J Olszewski

Andrew M Evens

Umar Farooq

Frequent Collaborators

Mazyar Shadman

Ajay K Gopal

Chaitra Ujjani

Ryan C Lynch